Thomas J. Schall

Companies

• Immuneering CorpBoard member Mar 12, 2024 to now¹
• ChemoCentryx, Inc.Board member Feb 8, 2012 to Oct 24, 2022²
• ChemoCentryx, Inc.Chief executive officer Feb 8, 2012 to Oct 24, 2022²
• ChemoCentryx, Inc.President Feb 8, 2012 to Oct 24, 2022²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• IImmuneering Corp IMRX74,530 shares³$270.5K at $3.63Jan 15, 2026
• CChemoCentryx, Inc.0 shares⁴Oct 20, 2022

As of each latest filing. The line shows shares held over time.

Recent filings

• Jan 15, 2026Bought 21,645 shares at $4.67 of Immuneering Corp³
• Jun 27, 2025Bought 9,500 shares at $3.66 of Immuneering Corp⁵
• Jun 17, 2025Bought 40,485 shares at $2.21 of Immuneering Corp⁶
• Mar 22, 2024Bought 2,900 shares at $2.55 of Immuneering Corp⁷
• Oct 20, 2022Returned to company 2,393,352 shares of ChemoCentryx, Inc.⁴
• Aug 4, 2022Sold 130,000 shares at $50.24 of ChemoCentryx, Inc.⁸
• Aug 4, 2022Exercised options 130,000 shares at $14.28 of ChemoCentryx, Inc.⁸
• Jan 1, 2022Shares withheld for tax 45,698 shares at $36.41 of ChemoCentryx, Inc.⁹
• Jan 1, 2022Exercised options 26,333 shares of ChemoCentryx, Inc.⁹
• Jan 1, 2022Exercised options 34,567 shares of ChemoCentryx, Inc.⁹
• Jan 1, 2022Exercised options 23,334 shares of ChemoCentryx, Inc.⁹
• Dec 1, 2021Exercised options 6,988 shares at $14.31 of ChemoCentryx, Inc.¹⁰
• Dec 1, 2021Exercised options 38,948 shares at $10.27 of ChemoCentryx, Inc.¹⁰